124 related articles for article (PubMed ID: 31987134)
1. Synergistic effect of the combination therapy on ovarian cancer cells under microfluidic conditions.
Flont M; Jastrzębska E; Brzózka Z
Anal Chim Acta; 2020 Mar; 1100():138-148. PubMed ID: 31987134
[TBL] [Abstract][Full Text] [Related]
2. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of photodynamic treatment and doxorubicin on triple negative breast cancer cells.
Yousefi Sadeghloo A; Khorsandi K; Kianmehr Z
Photochem Photobiol Sci; 2020 Nov; 19(11):1580-1589. PubMed ID: 33030191
[TBL] [Abstract][Full Text] [Related]
4. Leveraging a polycationic polymer to direct tunable loading of an anticancer agent and photosensitizer with opposite charges for chemo-photodynamic therapy.
Zhao M; Wan S; Peng X; Zhang B; Pan Q; Li S; He B; Pu Y
J Mater Chem B; 2020 Feb; 8(6):1235-1244. PubMed ID: 31957757
[TBL] [Abstract][Full Text] [Related]
5. pH-responsive and self-targeting assembly from hyaluronic acid-based conjugate toward all-in-one chemo-photodynamic therapy.
Wu J; Hu X; Liu R; Zhang J; Song A; Luan Y
J Colloid Interface Sci; 2019 Jul; 547():30-39. PubMed ID: 30933691
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of nanoencapsulated verteporfin's cytotoxicity using a microfluidic system.
Tokarska K; Bułka M; Bazylińska U; Jastrzębska E; Chudy M; Dybko A; Wilk KA; Brzózka Z
J Pharm Biomed Anal; 2016 Aug; 127():39-48. PubMed ID: 26997162
[TBL] [Abstract][Full Text] [Related]
7. Efficient combined near-infrared-triggered therapy: Phototherapy over chemotherapy in chitosan-reduced graphene oxide-IR820 dye-doxorubicin nanoplatforms.
Zaharie-Butucel D; Potara M; Suarasan S; Licarete E; Astilean S
J Colloid Interface Sci; 2019 Sep; 552():218-229. PubMed ID: 31128402
[TBL] [Abstract][Full Text] [Related]
8. Synergistic chemo-photodynamic therapy mediated by light-activated ROS-degradable nanocarriers.
Chen Y; Gao Y; Li Y; Wang K; Zhu J
J Mater Chem B; 2019 Jan; 7(3):460-468. PubMed ID: 32254733
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-loaded pH-responsive nanoparticles coated with chlorin e6 for drug delivery and synergetic chemo-photodynamic therapy.
Liang J; Jin X; Chen B; Hu J; Huang Q; Wan J; Hu Z; Wang B
Nanotechnology; 2020 May; 31(19):195103. PubMed ID: 31978912
[TBL] [Abstract][Full Text] [Related]
10. A multilayered cancer-on-a-chip model to analyze the effectiveness of new-generation photosensitizers.
Flont M; Jastrzębska E; Brzózka Z
Analyst; 2020 Oct; 145(21):6937-6947. PubMed ID: 32851999
[TBL] [Abstract][Full Text] [Related]
11. Yolk-Shell-Type Gold Nanoaggregates for Chemo- and Photothermal Combination Therapy for Drug-Resistant Cancers.
Choe HS; Shin MJ; Kwon SG; Lee H; Kim DK; Choi KU; Kim JH; Kim JH
ACS Appl Mater Interfaces; 2021 Nov; 13(45):53519-53529. PubMed ID: 34730926
[TBL] [Abstract][Full Text] [Related]
12. Oxygen-generating Hybrid Polymeric Nanoparticles with Encapsulated Doxorubicin and Chlorin e6 for Trimodal Imaging-Guided Combined Chemo-Photodynamic Therapy.
Hu D; Chen L; Qu Y; Peng J; Chu B; Shi K; Hao Y; Zhong L; Wang M; Qian Z
Theranostics; 2018; 8(6):1558-1574. PubMed ID: 29556341
[TBL] [Abstract][Full Text] [Related]
13. Carboxymethyl-hexanoyl Chitosan Nanodroplets for Ultrasonic Imaging and Drug Delivery to Tumor.
Jinsui Y; Bing S; Muhua L; Yue L; Jianyi L; Meng D; Kuan C; Chaopin Y; Hui Z; Zhiyi C
Curr Pharm Des; 2018; 24(15):1682-1688. PubMed ID: 29766795
[TBL] [Abstract][Full Text] [Related]
14. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.
Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ
Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976
[TBL] [Abstract][Full Text] [Related]
15. Verteporfin mediated sequence dependent combination therapy against ovarian cancer cell line.
Erdem SS; Obeidin VA; Yigitbasi T; Tumer SS; Yigit P
J Photochem Photobiol B; 2018 Jun; 183():266-274. PubMed ID: 29747146
[TBL] [Abstract][Full Text] [Related]
16. A nano-complex system to overcome antagonistic photo-chemo combination cancer therapy.
Lim C; Moon J; Sim T; Won WR; Lee ES; Youn YS; Oh KT
J Control Release; 2019 Feb; 295():164-173. PubMed ID: 30592982
[TBL] [Abstract][Full Text] [Related]
17. Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo.
del Carmen MG; Rizvi I; Chang Y; Moor AC; Oliva E; Sherwood M; Pogue B; Hasan T
J Natl Cancer Inst; 2005 Oct; 97(20):1516-24. PubMed ID: 16234565
[TBL] [Abstract][Full Text] [Related]
18. Biotin-conjugated PEGylated porphyrin self-assembled nanoparticles co-targeting mitochondria and lysosomes for advanced chemo-photodynamic combination therapy.
Purushothaman B; Choi J; Park S; Lee J; Samson AAS; Hong S; Song JM
J Mater Chem B; 2019 Jan; 7(1):65-79. PubMed ID: 32254951
[TBL] [Abstract][Full Text] [Related]
19. Histological Subtype of Ovarian Cancer as a Determinant of Sensitivity to Formamidine Derivatives of Doxorubicin - in Vitro Comparative Studies with SKOV-3 and ES-2 Cancer Cell Lines.
Denel-Bobrowska M; Lukawska M; Oszczapowicz I; Marczak A
Asian Pac J Cancer Prev; 2016; 17(9):4223-4231. PubMed ID: 27797222
[TBL] [Abstract][Full Text] [Related]
20. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy.
Gao D; Lo PC
J Control Release; 2018 Jul; 282():46-61. PubMed ID: 29673646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
